Skip to main content
. 2023 Feb 13;26(6):1238–1253. doi: 10.1017/S1368980023000095

Table 6.

Prevalence of DS use by number of CDMC (nineteen major code groups only) in the US military dietary supplement use study

DS category Proportion (%) of DS users P-value (Chi-square) P-value (linear trend)
No CDMC (n 7905) 1–2 CDMC (n 9772) 3–4 CDMC (n 5462) ≥5 CDMC (n 3541)
Any DS 72·0 72·7 76·5 77·8 <0·01 <0·01
MVM 40·8 43·6 48·5 49·6 <0·01 <0·01
Individual vitamin/minerals 25·3 28·8 35·3 41·8 <0·01 <0·01
Proteins/AA 45·2 42·7 41·2 35·8 <0·01 <0·01
Combination products 45·1 43·9 45·4 42·6 0·02 0·11
Prohormones 4·6 4·8 5·2 4·9 0·42 0·11
Herbal products 16·8 19·9 22·3 24·9 <0·01 <0·01
Joint health products 7·7 9·2 10·9 11·5 <0·01 <0·01
Fish oils 21·6 22·9 23·8 24·7 <0·01 <0·01
Other DS 6·2 7·2 8·7 10·8 <0·01 <0·01

DS, dietary supplement; CDMC, clinically diagnosed medical conditions; MVM, multivitamin/multimineral; AA, amino acid; ICD-10, International Classification of Diseases, Clinical Modification, Revision 10 (ICD-10 code groups; refer to Table 2 for specifics).